Schedule 13D ownership disclosure
EYEPOINT PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233G100
Event date: 2018-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-111724
- Form type
- SC 13D
- Filer
- EW Healthcare Partners, L.P.
- CIK
- CIK 1612343
- Filed
- Apr 10, 2018
- Reporting period
- Mar 28, 2018
- Description
- Schedule 13D beneficial ownership